Fifth International Hospital Diabetes Meeting May 8-9, 2015 at the Hyatt Regency San Francisco Airport 1333 Bayshore Highway, Burlingame, CA 94010 Regency Ballroom Friday May 8, 2015 08:00 Welcome David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California Keynote Address 08:05 Hospital Safety for Diabetes: The Joint Commission Perspective Erin S. DuPree, MD, FACOG Joint Commission Center for Transforming Healthcare, Oakbrook Terrace, Illinois Session 1: Measuring Glucose in Hospitalized and Critically Ill Patients 08:35 Glucometrics – What to Report Greg Maynard, MD, MSc, SFHM UC Davis, Sacramento, California 08:55 Glucose Variability in the Hospital Setting: Causes and Solutions Gerry Rayman, MD, FRCP Ipswich Hospital Diabetes Center, Ipswich, UK 09:15 POC Blood Glucose Monitoring and Impact of FDA Guidelines for Critically Ill Patients Mitchell G. Scott, PhD, DABCC Washington University, Saint Louis, Missouri 09:45 Impact of CMS Guidelines on POC BGM in Critically Ill Patients David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California 09:55 Group Discussion 10:15 Break Session 2: Glycemic Targets in Various Settings 10:40 ICU Stanley A. Nasraway, MD Tufts Medical Center, Boston Massachusetts 11:00 Non-ICU Garry S. Tobin, MD Washington University, Saint Louis, Missouri 11:20 Pediatric ICU Darrell M. Wilson, MD Stanford University, Stanford, California 11:40 Transitions in Diabetes Care: Inpatient to Outpatient Amisha Wallia, MD, MS Northwestern Medical Group, Chicago, Illinois 12:00 Group Discussion 12:20 Lunch 12:40 Lunch Program – Avoiding Bloodborne Diseases Avoiding Bloodborne Virus Disease Transmission from Assisted Monitoring of Blood Glucose in the Hospital; a Pathologist‘s Perspective Sharon Geaghan, MD Stanford University, Stanford, California Christel Marchand Aprigliano StripSafely, Tampa, Florida 13:20 Break Session 3: Technology 13:50 BGM in the Hospital – State of the Art Mitchell G. Scott, PhD, DABCC Washington University, Saint Louis, Missouri 14:10 Continuous Glucose Monitoring in the Hospital Stanley A. Nasraway, MD Tufts Medical Center, Boston Massachusetts 14:30 Computerized Insulin Infusion Programs (Glucommander and Others) Guillermo Umpierrez, MD Emory University, Atlanta, Georgia 14:50 Regulation of Glucose Monitoring and Insulin Dosing Software for Hospitalized Patients Alberto Gutierrez, PhD U.S. Food and Drug Administration, Silver Spring, Maryland 15:10 Group Discussion 15:30 Break Session 4: Glucose Management Teams 15:55 The Role of Certified Diabetes Educators (CDEs) Jane Jeffrie Seley, DNP, MPH, GNP, BC-ADM, CDE, CDTC New York-Presbyterian/Weill Cornell, New York, New York 16:15 Collaborative Model to Enhance Surgical Diabetes Patient Care Curtiss B. Cook, MD Mayo Clinic, Scottsdale, Arizona 16:35 The Virtual Inpatient Glucose Management Service Robert J. Rushakoff, MD UC San Francisco, San Francisco, California 16:55 Group Discussion 17:10 Adjourn Saturday May 9, 2015 08:00 Introduction David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE Mills-Peninsula Health Services, San Mateo, California Session 5: Insulin Dosing and Safety 08:05 Algorithms Greg Maynard, MD, MSc, SFHM UC Davis, Sacramento, California 08:25 Decision Support Software Thomas Pieber, MD Medical University of Graz, Graz, Austria 08:45 Creating User-Friendly Insulin Order Sets: Balancing Safety and Efficacy Jane Jeffrie Seley, DNP, MPH, GNP, BC-ADM, CDE, CDTC New York-Presbyterian/Weill Cornell, New York, New York 09:05 Pump Safety in the Hospital in Various Settings Including OR and Radiology Robert J. Rushakoff, MD UC San Francisco, San Francisco, California 09:25 Group Discussion 09:50 Break Session 6: Hypoglycemia 10:15 Mechanisms/Symptoms/Frequency Thomas Pieber, MD Medical University of Graz, Graz, Austria 10:35 Prevention Garry S. Tobin, MD Washington University, Saint Louis, Missouri 10:55 Outcomes Mikhail Kosiborod, MD Saint Luke’s Mid America Heart Institute, Kansas City, Missouri 11:15 The Economic Burden of Hypoglycemia Robert A. Vigersky, MD Medical Director, Medical Affairs, Medtronic Diabetes Professor of Medicine Uniformed Services University of the Health Sciences Director Emeritus Diabetes Institute Walter Reed National Military Medical Center 11:35 Group Discussion 12:00 Lunch Session 7: Special Populations 13:00 Steroids, Tube Feeding, and TPN Boris Draznin, MD, PhD University of Colorado, Aurora, Colorado 13:20 Special Situations: Surgery Mark J. Rice, MD Vanderbilt University, Nashville, Tennessee 13:40 Transplant Management Amisha Wallia, MD, MS Northwestern Medical Group, Chicago, Illinois 14:00 Foot Disease in the Hospital Gerry Rayman, MD, FRCP Ipswich Hospital Diabetes Center, Ipswich, UK 14:20 Group Discussion 14:45 Break Session 8: Novel Therapeutics 15:10 New Insulins Robert A. Vigersky, MD Medical Director, Medical Affairs, Medtronic Diabetes Professor of Medicine Uniformed Services University of the Health Sciences Director Emeritus Diabetes Institute Walter Reed National Military Medical Center 15:35 Insulin Pump Therapy In The Perioperative Period: Update on a Quality Initiative Curtiss B. Cook, MD Mayo Clinic, Scottsdale, Arizona 16:00 SGLT2 Inhibitors Mikhail Kosiborod, MD Saint Luke’s Mid America Heart Institute, Kansas City, Missouri 16:25 Group Discussion 16:50 Closing Remarks Robert A. Vigersky, MD Medical Director, Medical Affairs, Medtronic Diabetes Professor of Medicine Uniformed Services University of the Health Sciences Director Emeritus Diabetes Institute Walter Reed National Military Medical Center 17:00 Adjourn
© Copyright 2024